Navigation Links
Being small has its advantages, if you are a leaf
Date:7/6/2011

The size of leaves can vary by a factor of 1,000 across plant species, but until now, the reason why has remained a mystery. A new study by an international team of scientists led by UCLA life scientists goes a long way toward solving it.

In research federally funded by the National Science Foundation, the biologists found that smaller leaves are structurally and physiologically better adapted to dry soil because of their distinct vein systems.

The research will be published in an upcoming print issue of the journal Plant Physiology and is currently available in the journal's online edition.

"A hike in dry areas, such as the Santa Monica Mountains, proves that leaves can be small. But if you are in the tropical forest, many leaves are enormous," said Lawren Sack, a UCLA professor of ecology and evolutionary biology and senior author of the research.

This biogeographic trend smaller leaves in drier areas may be the best recognized in plant ecology, true at both the local and global scales, but it had evaded direct explanation, Sack said.

Sack and his research team focused on deciphering the meaning of the huge diversity in the patterns of veins across plants. They found that small leaves' major veins those you can see with the naked eye are spaced more closely together and are of greater length, relative to the leaf's size, than those of larger leaves.

This redundancy of major veins, the researchers say, protects the leaves from the effects of embolism bubbles that form in their "water pipes" during drought because it provides alternate routes for water to flow around vein blockages.

"Even with strong drought that forms embolism in the veins, a small leaf maintains function in its vein system and can keep functioning for water transport," Sack said.

"Unlike people, plants don't seem to have a complex hierarchy of needs give them sun, water and nutrients, and they
'/>"/>

Contact: Stuart Wolpert
swolpert@support.ucla.edu
310-206-0511
University of California - Los Angeles
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. BUSM names Deborah Frank, M.D., inaugural professors in child health and well-being
2. Inability to cry in patients with Sjogrens syndrome affect emotional and mental well-being
3. Its not easy being green
4. Missouri elk are being reintroduced in the wrong part of the state, MU anthropologist says
5. DNA stretching -- A new technique being carried out at CIC microGUNE to detect illnesses
6. Plant breeding is being transformed by advances in genomics and computing
7. Sensors to detect explosives, monitor food being developed at UH
8. Being good moms couldnt save the woolly mammoth
9. Study suggests that being too clean can make people sick
10. Biodiesel from sewage sludge within pennies a gallon of being competitive
11. Selected highlights of the research being presented at the Experimental Biology 2010 meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2014)... Research and Markets , ... http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of the ...  report to their offering. One ... in technology. With continuous advances in technology, it ... latest standard that meets the needs and expectations ...
(Date:12/11/2014)... N.C. , Dec. 10, 2014  That blood pressure ... quite a while. Hypertension – the medical term for high ... the early 1800s, and the inflatable cuff that,s used in ... doesn,t, however, mean there,s nothing new about hypertension, its triggers ... long-held beliefs about the condition and the best ways to ...
(Date:12/10/2014)... NEW YORK , Dec. 8, 2014 You,ve ... online banking account but can,t remember your password, site key ... birthday? Who was your first grade teacher? ... launches the app that will finally put an ... PINs – 1U TM . 1U leverages a ...
Breaking Biology News(10 mins):Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3
... are old. Really old, in fact, which comes as a ... tree growth in the world's largest tropical region. , Using ... Trumbore, found that up to half of all trees greater ... old. Some of the trees, Trumbore said, are as much ...
... National Human Genome Research Institute (NHGRI), both part ... launched a comprehensive effort to accelerate our understanding ... application of genome analysis technologies, especially large-scale genome ... Atlas (TCGA), will begin with a pilot project ...
... University of Pennsylvania School of Medicine have discovered that ... (pre-mRNA), a process once believed to only take place ... capability in dendrites, the investigators hope to relate this ... dysfunction. Senior author James Eberwine, PhD, Professor of Pharmacology, ...
Cached Biology News:Amazon trees much older than assumed, raising questions on global climate impact of region 2NIH launches comprehensive effort to explore cancer genomics 2NIH launches comprehensive effort to explore cancer genomics 3NIH launches comprehensive effort to explore cancer genomics 4RNA splicing occurs in nerve-cell dendrites 2RNA splicing occurs in nerve-cell dendrites 3
(Date:12/19/2014)... Dec. 19, 2014 Research and Markets ... of the "Technology Innovations in Smart Fabrics ... http://photos.prnewswire.com/prnh/20130307/600769 ... Fabrics" offers a detailed assessment on technological advancements ... Findings: 1. The Smart Fabrics ...
(Date:12/19/2014)... MA (PRWEB) December 18, 2014 LayerBio ... for ophthalmology and wound care. The National Eye Institute ... awarded LayerBio a Phase I SBIR grant to develop ... Cataracts are the most common cause of vision loss ... of blindness worldwide. According to Dr. Ken Mandell, LayerBio’s ...
(Date:12/19/2014)... (PRWEB) December 18, 2014 iLab Solutions, ... the appointment of Siri Bryant as the new Director ... Director of Core Implementations. These two new leadership positions ... customer service by ensuring that iLab continues to meet ... the last four years, iLab has been deployed at ...
(Date:12/19/2014)... (PRWEB) December 18, 2014 With only ... time special on Sartorius Biohit products . The ... mLINE pipettes, Picus Electronic Pipette Trade-in Program, and free ... and Safety officers around the world. They are ideal ... Other features include:, ,     Full volume range ...
Breaking Biology Technology:Technology Innovations in Smart Fabrics (Technical Insights) 2LayerBio Awarded NIH Grant to Develop a Drug Delivery Device for Cataract Surgery 2iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2Major Pipette Distributor Pipette.com Announces Sartorius Year End Specials 2
... New Findings Also Demonstrate Treatment Results in Improvements in ... Function and Health-Related Quality ... than half of patients,receiving every four week subcutaneous injections ... investigational therapy, experienced sustained,improvements in the joint and skin ...
... Cephalosporin in,Development for Complicated Skin and Skin Structure ... Oct. 27, 2008 Forest,Laboratories, Inc. (NYSE: ... I, a,globally conducted, multi-center, Phase III clinical trial, ... and Chemotherapy /,Infectious Diseases Society of America 46th ...
... 27 Trubion Pharmaceuticals Inc.,(Nasdaq: TRBN ... Phase 1/2a study,demonstrating that repeat administration with ... improvements in rheumatoid arthritis,(RA) signs and symptoms ... Trubion also announced positive results following preliminary,analyses ...
Cached Biology Technology:One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 2One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 3One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 4One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 5One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 6One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 7One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 8One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 9Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA 2Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA 3Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA 4Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA 5Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA 6Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA 7Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA 8Trubion Reports Re-treatment Results Following Phase 1/2a and Phase 2b Studies Evaluating TRU-015 for Rheumatoid Arthritis 2Trubion Reports Re-treatment Results Following Phase 1/2a and Phase 2b Studies Evaluating TRU-015 for Rheumatoid Arthritis 3Trubion Reports Re-treatment Results Following Phase 1/2a and Phase 2b Studies Evaluating TRU-015 for Rheumatoid Arthritis 4Trubion Reports Re-treatment Results Following Phase 1/2a and Phase 2b Studies Evaluating TRU-015 for Rheumatoid Arthritis 5
HSD17B3 Immunogen: HSD17B3 (NP_000188, 29 a.a. ~ 120 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Rad51, N-terminal...
Phospho-mu-Opioid Receptor (Ser375) Antibody...
Rabbit polyclonal to WWOX8 ( Abpromise for all tested applications). entrezGeneID: 51741 SwissProtID: Q9NZC7-8...
Biology Products: